SR
Sodhi Rajwant Chairman & CEO
C-suite M
US US · SEC (Form 4)
Discover the detailed record of transactions filed by Sodhi Rajwant, Chairman & CEO. Officer active across 3 companies, notably RESMED INC. Aggregated, 15 filings have been published. Total volume traded: €3m. The latest transaction was disclosed on 18 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 15 total
0735 shares 0
Common Stock
SEC:0001438133-22-000101:0 · 18 May 2022
01,069 shares 0
Common Stock
SEC:0001438133-22-000004 · 4 Jan 2022
01,069 shares 0
Common Stock
SEC:0001438133-22-000004:0 · 4 Jan 2022
€365,356 1,500 shares @ €243.5709 0.0010% mcap 24.2% of flow
ResMed Common Stock
SEC:0001127602-21-024859 · 1 Sept 2021
€365,356 1,500 shares @ €243.5709 0.0010% mcap 12.1% of flow
ResMed Common Stock
SEC:0001127602-21-024859:0 · 1 Sept 2021
04,066 shares 0
ResMed Common Stock
SEC:0001127602-21-024092 · 19 Aug 2021
04,066 shares 0
ResMed Common Stock
SEC:0001127602-21-024092:0 · 19 Aug 2021
€339,799 1,500 shares @ €226.533 0.0009% mcap 22.5% of flow
ResMed Common Stock
SEC:0001127602-21-022839 · 2 Aug 2021
€339,799 1,500 shares @ €226.533 0.0009% mcap 11.3% of flow
ResMed Common Stock
SEC:0001127602-21-022839:0 · 2 Aug 2021
€311,137 1,500 shares @ €207.4245 0.0008% mcap 20.6% of flow
ResMed Common Stock
SEC:0001127602-21-021160 · 1 Jul 2021
€311,137 1,500 shares @ €207.4245 0.0008% mcap 10.3% of flow
ResMed Common Stock
SEC:0001127602-21-021160:0 · 1 Jul 2021
€254,298 1,500 shares @ €169.5318 0.0007% mcap 16.9% of flow
ResMed Common Stock
SEC:0001127602-21-018662 · 1 Jun 2021
€254,298 1,500 shares @ €169.5318 0.0007% mcap 8.4% of flow
ResMed Common Stock
SEC:0001127602-21-018662:0 · 1 Jun 2021
€236,915 1,500 shares @ €157.9435 0.0006% mcap 15.7% of flow
ResMed Common Stock
SEC:0001127602-21-015115 · 3 May 2021
€236,915 1,500 shares @ €157.9435 0.0006% mcap 7.9% of flow
ResMed Common Stock
SEC:0001127602-21-015115:0 · 3 May 2021
About Sodhi Rajwant Rajwant Sodhi is an executive at RESMED INC.